|
 |
|
To Novaliq, the continuous expansion of its product pipeline in collaboration with universities and other medical/biopharmaceutical companies is of great importance.
In pursuing this strategy, Novaliq has formed research and development cooperations with:
University of Cologne, with Prof. Claus Cursiefen and Dr. Philipp Steren in the field of ophthalmic drug delivery for the anterior segment of the eye
University of Strathclyde, with Prof. Clive Wilson in the field of ophthalmic drug delivery
University of Mannheim, with Prof. Benito Yard, Dr. Charalambos Tsagogiorgas and Simone Hoeger in the field of organ transplantation. In this collaboration, research with N-Octanyl-Dopamin has been performed to reduce transplantation related ischemia damage.
University of Oxford, with Dr. Daniel Brandhorst, in the field of islet preservation
University of Halle, with Prof. Wohlrab for the development of a novel topical carrier for Tacrolimus in Psoriasis |
|
|
|
|
|
|
© 2011 Novaliq GmbH Germany. All rights reserved. |
|
|
